scholarly journals Polymer Nanoparticles: Synthesis and Assembly of Click-Nucleic-Acid-Containing PEG-PLGA Nanoparticles for DNA Delivery (Adv. Mater. 24/2017)

2017 ◽  
Vol 29 (24) ◽  
Author(s):  
Albert Harguindey ◽  
Dylan W. Domaille ◽  
Benjamin D. Fairbanks ◽  
Justine Wagner ◽  
Christopher N. Bowman ◽  
...  
2017 ◽  
Vol 29 (24) ◽  
pp. 1700743 ◽  
Author(s):  
Albert Harguindey ◽  
Dylan W. Domaille ◽  
Benjamin D. Fairbanks ◽  
Justine Wagner ◽  
Christopher N. Bowman ◽  
...  

2019 ◽  
Vol 2 (2) ◽  
pp. 898-909 ◽  
Author(s):  
Daniel N. F. Bajj ◽  
Michael V. Tran ◽  
Hsin-Yun Tsai ◽  
Hyungki Kim ◽  
Nathan R. Paisley ◽  
...  

Pharmaceutics ◽  
2022 ◽  
Vol 14 (1) ◽  
pp. 165
Author(s):  
Ellen S. Hauck ◽  
James G. Hecker

Appropriate gene delivery systems are essential for successful gene therapy in clinical medicine. Lipid-mediated nucleic acid delivery is an alternative to viral vector-mediated gene delivery and has the following advantages. Lipid-mediated delivery of DNA or mRNA is usually more rapid than viral-mediated delivery, offers a larger payload, and has a nearly zero risk of incorporation. Lipid-mediated delivery of DNA or RNA is therefore preferable to viral DNA delivery in those clinical applications that do not require long-term expression for chronic conditions. Delivery of RNA may be preferable to non-viral DNA delivery in some clinical applications, since transit across the nuclear membrane is not necessary, and onset of expression with RNA is therefore even faster than with DNA, although both are faster than most viral vectors. Delivery of RNA to target organ(s) has previously been challenging due to RNA’s rapid degradation in biological systems, but cationic lipids complexed with RNA, as well as lipid nanoparticles (LNPs), have allowed for delivery and expression of the complexed RNA both in vitro and in vivo. This review will focus on the non-viral lipid-mediated delivery of RNAs, including mRNA, siRNA, shRNA, and microRNA, to the central nervous system (CNS), an organ with at least two unique challenges. The CNS contains a large number of slowly dividing or non-dividing cell types and is protected by the blood brain barrier (BBB). In non-dividing cells, RNA-lipid complexes demonstrated increased transfection efficiency relative to DNA transfection. The efficiency, timing of the onset, and duration of expression after transfection may determine which nucleic acid is best for which proposed therapy. Expression can be seen as soon as 1 h after RNA delivery, but duration of expression has been limited to 5–7 h. In contrast, transfection with a DNA lipoplex demonstrates protein expression within 5 h and lasts as long as several weeks after transfection.


2007 ◽  
Vol 1019 ◽  
Author(s):  
Monica Rabinovich ◽  
Shankari N. Somayaji ◽  
Rajeev Raghavan Pillai ◽  
Michael C. Hudson ◽  
J. Kent Ellington ◽  
...  

AbstractAntibiotic-encapsulated PLA and PLGA nanoparticles were prepared by the single emulsion-solvent evaporation technique. Different PLA and PLGA systems were prepared, varying the copolymer composition and the amount of the surfactant polyvinyl alcohol. Characterization and drug loading studies were performed by UV-Visible spectrophotometry, dynamic light scattering, and scanning electron microscopy (SEM).Simultaneously, in order to model the diffusion of the nanoparticles within the osteoblast, QDs such as functionalized InGaP/ZnS and polymer encapsulated InGaP/ZnS nanoparticles were added to confluent cultures of primary mouse osteoblasts. Following PreFer fixation, cultures were examined via confocal microscopy. QDs were clearly visible within osteoblasts.


2013 ◽  
Vol 50 (7) ◽  
pp. 513-518 ◽  
Author(s):  
Yusuke Tsukada ◽  
Hiroyuki Tsujimoto ◽  
Hajime Watanabe ◽  
Takayuki Sugimoto ◽  
Osami Nakano ◽  
...  

2019 ◽  
Vol 20 (4) ◽  
pp. 1683-1690 ◽  
Author(s):  
Albert Harguindey ◽  
Shambojit Roy ◽  
Alexander W. Harris ◽  
Benjamin D. Fairbanks ◽  
Andrew P. Goodwin ◽  
...  

Polymers ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 341
Author(s):  
Veronika Subjakova ◽  
Veronika Oravczova ◽  
Tibor Hianik

Polymer nanoparticles and nano/micromotors are novel nanostructures that are of increased interest especially in the diagnosis and therapy of cancer. These structures are modified by antibodies or nucleic acid aptamers and can recognize the cancer markers at the membrane of the cancer cells or in the intracellular side. They can serve as a cargo for targeted transport of drugs or nucleic acids in chemo- immuno- or gene therapy. The various mechanisms, such as enzyme, ultrasound, magnetic, electrical, or light, served as a driving force for nano/micromotors, allowing their transport into the cells. This review is focused on the recent achievements in the development of polymer nanoparticles and nano/micromotors modified by antibodies and nucleic acid aptamers. The methods of preparation of polymer nanoparticles, their structure and properties are provided together with those for synthesis and the application of nano/micromotors. The various mechanisms of the driving of nano/micromotors such as chemical, light, ultrasound, electric and magnetic fields are explained. The targeting drug delivery is based on the modification of nanostructures by receptors such as nucleic acid aptamers and antibodies. Special focus is therefore on the method of selection aptamers for recognition cancer markers as well as on the comparison of the properties of nucleic acid aptamers and antibodies. The methods of immobilization of aptamers at the nanoparticles and nano/micromotors are provided. Examples of applications of polymer nanoparticles and nano/micromotors in targeted delivery and in controlled drug release are presented. The future perspectives of biomimetic nanostructures in personalized nanomedicine are also discussed.


2021 ◽  
Vol 22 (3) ◽  
pp. 1127-1136
Author(s):  
Alex J. Anderson ◽  
Emerson Grey ◽  
Nicholas J. Bongiardina ◽  
Christopher N. Bowman ◽  
Stephanie J. Bryant

Sign in / Sign up

Export Citation Format

Share Document